Skip to content

Constructing a tool for understanding and managing Childrens respiratory problems

Development and validation of a clinical repertory on paediatric upper respiratory ailments - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063040
Enrollment
40
Registered
2024-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: Homoeopathic Medicine: The selection of medicines is done through proper case-taking and repertorization. Their administration follows homoeopathic principles, starting from the 30th po

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group less than 18 years of age. Both sexes. Presenting with symptoms of upper respiratory ailments

Exclusion criteria

Exclusion criteria: Patients of age group more than 18 years of age. Absence of Upper Respiratory Ailments Severe respiratory distress requiring immediate medical intervention. Chronic respiratory conditions (e.g., asthma, cystic fibrosis) that may confound the diagnosis. History of major surgical interventions related to the respiratory system. Known allergies to medications used in the study

Design outcomes

Primary

MeasureTime frame
To provide healthcare providers with a standardized tool to improve accuracy, efficiency, and healthcare outcomes in the treatment of upper respiratory conditions in paediatric patients. The outcome of the study involves evaluating the effectiveness and reliability of the developed clinical repertory for paediatric upper respiratory ailments.Timepoint: Medicines are given and observed for 15 days and consequently for 6 months

Secondary

MeasureTime frame
The assessment will focus on several key parameters. Validity, Clinical utility, Impact on patient outcomes, User satisfaction, contribution to knowledgeTimepoint: Medicines are given & observed for 15 days & consequently for 6 months

Countries

India

Contacts

Public ContactDr Wasia Sulthana B

Sarada Krishna Homoeopathic medical college

dissert02@gmail.com9443500675

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026